Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SYSMEX IMMATURE RETICULOCYTE FRACTION (IRF) PARAMETER

K-Number: K971736 · 1997-08-26

ApplicantSysmex Corp.
Decision Date1997-08-26
Product CodeGKZ
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

SYSMEX IMMATURE RETICULOCYTE FRACTION (IRF) PARAMETER is the device name listed in this FDA 510(k) record. The listed applicant is Sysmex Corp.. It received FDA 510(k) clearance on 1997-08-26 under 510(k) number K971736. The device is classified under product code GKZ. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SYSMEX IMMATURE RETICULOCYTE FRACTION (IRF) PARAMETER?

SYSMEX IMMATURE RETICULOCYTE FRACTION (IRF) PARAMETER is a medical device that received FDA 510(k) clearance on 1997-08-26. The listed applicant is Sysmex Corp.. The 510(k) number is K971736.

When did SYSMEX IMMATURE RETICULOCYTE FRACTION (IRF) PARAMETER receive FDA 510(k) clearance?

SYSMEX IMMATURE RETICULOCYTE FRACTION (IRF) PARAMETER received FDA 510(k) clearance on 1997-08-26, under 510(k) number K971736.

Who is the listed applicant for SYSMEX IMMATURE RETICULOCYTE FRACTION (IRF) PARAMETER?

The FDA 510(k) record lists Sysmex Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SYSMEX IMMATURE RETICULOCYTE FRACTION (IRF) PARAMETER?

The FDA product code for SYSMEX IMMATURE RETICULOCYTE FRACTION (IRF) PARAMETER is GKZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Sysmex Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K012372SYSMEX UF-50K992875SYSMEX XE-2100, AUTOMATATED HEMATOLOGY ANALYZERK981950SYSMEX R-3500, AUTOMATED RETICCULOCYTE ANALYZER, MODEL R-3500K981761SYSMEX KX-21, AUTOMATED HEMATOLOGY ANALYZERK964946SYSMEX CA-1000/SYSMEX CA-5000K964375SYSMEX SE/RAM-1

View all 18 devices →

Related Devices (Code: GKZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260781Yumizen H550HORIBA ABX SASK253212XR-Series (XR-10, XR-20) Automated Hematology AnalyzersSysmex America, Inc.K243348Athelas HomeAthelas, Inc.K251249Tru Hematology TestTruvian Sciences, Inc.K250943Sysmex XR-Series (XR-10) Automated Hematology AnalyzerSysmex America, Inc.K251371Sysmex XR-Series (XR-20) Automated Hematology AnalyzerSysmex America, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑